The leading goal was to establish ideal analytical targets by examining human hepatocyte incubation samples with significant-resolution mass spectrometry (HRMS) and to substantiate the outcome in genuine urine specimens and to find out AB-FUBINACA's metabolic security in human liver microsomes and in comparison hepatocyte and urine benefits with in